REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jiangsu Recbio Technology Company Limited (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jiangsu Recbio Technology Company Limited Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Jiangsu Recbio Technology Company Limited is an innovative vaccine company dedicated to the development and commercialization of safer and more effective innovative vaccines. The company's main products include HPV vaccine, recombinant COVID-19 vaccine, recombinant zoster vaccine, recombinant quadrivalent influenza vaccine, etc. The company was established in 2012 and is headquartered in Taizhou City, China.

Headquarters
Room A217, Vaccine Engineering Center, China Medical City, Jiangsu Province
Taizhou; Zhejiang;

Contact Details: Purchase the Jiangsu Recbio Technology Company Limited report to view the information.

Website: http://www.recbio.cn

Basic Information
Total Employees:
Purchase the Jiangsu Recbio Technology Company Limited report to view the information.
Outstanding Shares:
Purchase the Jiangsu Recbio Technology Company Limited report to view the information.
Registered Capital:
Purchase the Jiangsu Recbio Technology Company Limited report to view the information.
Financial Auditors:
Purchase the Jiangsu Recbio Technology Company Limited report to view the information.
Incorporation Date:
May 18, 2012
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
18.49%
Purchase this report to view the information.
8.34%
Purchase this report to view the information.
6.32%
Purchase this report to view the information.
4.56%
Purchase this report to view the information.
0.06%
Subsidiaries
Beijing Abzymo Biosciences Co., Ltd.
100%
Wuhan Ruike Technology Co., Ltd
100%
Wuhan Recogen Biotechnology Co., Ltd.
55%
Company Performance
Financial values in the chart are available after Jiangsu Recbio Technology Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total operating revenue
299.65%▲
Operating profit (EBIT)
24.4%▲
EBITDA
30.78%▲
Net Profit (Loss) for the Period
9.84%▲
Total assets
-8.31%▼
Total equity
-38.33%▼
Return on Equity (ROE)
-9.44%▼
Debt to Equity Ratio
42.33%▲
Quick Ratio
-2.9%▼
Cash Ratio
-2.7%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Hinova Pharmaceuticals Inc.
 
Zhaoke Ophthalmology Limited (Hong Kong) (兆科眼科有限公司 (香港))
Beijing Luzhu Biotechnology Company Limited
 
China Sxt Pharmaceuticals Inc.
Shouyao Holdings Co.,Ltd (首药控股(北京)股份有限公司)
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo